Get started
Work

1304P Brigatinib (BRG) vs crizotinib (CRZ) in Asian vs non-Asian patients (pts): Update from ALTA-1L

Year: 2020
Type: article
DOI: 10.1016/j.annonc.2020.08.1618
Authors: M-J. Ahn, H.R. Kim, J.C-H. Yang, J-Y. Han, J.Y-C. Li, M.J. Hochmair, G-C. Chang, A. Delmonte, K.H. Lee, M.R. Garcia Campelo, C. Gridelli, A. Spira, R. Califano, F. Griesinger, S. Ghosh, E. Felip, D-W. Kim, P. Zhang, S. Popat, D.R. Camidge
Institutions: Samsung Medical Center, Sungkyunkwan University, Yonsei University, Yonsei Cancer Hospital, National Taiwan University Hospital, National Cancer Center, Taichung Veterans General Hospital, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Chungbuk National University Hospital, Complexo Hospitalario Universitario A Coruña, Azienda Ospedaliera S.Giuseppe Moscati, Virginia Cancer Specialists, National Health Service, The Christie NHS Foundation Trust, Carl von Ossietzky Universität Oldenburg, Pius Hospital Oldenburg, Guy's and St Thomas' NHS Foundation Trust, Vall d'Hebron Hospital Universitari, Seoul National University, Seoul National University Hospital, Takeda Oncology (United States), Institute of Cancer Research, Royal Marsden Hospital, University of Colorado Cancer Center
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3088182063
FWCI: 0.282
Cites:
Cited by: 2
Related to: 10